WO2005065713A3 - Arzneimittel zur topischen applikation bei tieren - Google Patents
Arzneimittel zur topischen applikation bei tieren Download PDFInfo
- Publication number
- WO2005065713A3 WO2005065713A3 PCT/EP2005/000067 EP2005000067W WO2005065713A3 WO 2005065713 A3 WO2005065713 A3 WO 2005065713A3 EP 2005000067 W EP2005000067 W EP 2005000067W WO 2005065713 A3 WO2005065713 A3 WO 2005065713A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- animals
- topically applied
- applied medicament
- medicament
- pelt
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Zoology (AREA)
- Dermatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BRPI0506753-7A BRPI0506753A (pt) | 2004-01-10 | 2005-01-07 | medicamento para a aplicação tópica em animais |
NZ548422A NZ548422A (en) | 2004-01-10 | 2005-01-07 | Topically applied medicament for animals |
EP05700727A EP1706097A2 (de) | 2004-01-10 | 2005-01-07 | Arzneimittel zur topischen applikation bei tieren |
US10/585,608 US20080255125A1 (en) | 2004-01-10 | 2005-01-07 | Topically Applied Medicament for Animals |
AU2005203884A AU2005203884B2 (en) | 2004-01-10 | 2005-01-07 | Topically applied medicament for animals |
CA2552909A CA2552909C (en) | 2004-01-10 | 2005-01-07 | Pharmaceuticals for topical application in animals |
JP2006548218A JP5704738B2 (ja) | 2004-01-10 | 2005-01-07 | 動物における局所適用のための医薬 |
NO20063626A NO20063626L (no) | 2004-01-10 | 2006-08-10 | Topisk anvendt medikament for dyr |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102004001558.9 | 2004-01-10 | ||
DE102004001558A DE102004001558A1 (de) | 2004-01-10 | 2004-01-10 | Arzneimittel zur topischen Applikation bei Tieren |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005065713A2 WO2005065713A2 (de) | 2005-07-21 |
WO2005065713A3 true WO2005065713A3 (de) | 2006-05-11 |
Family
ID=34744661
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2005/000067 WO2005065713A2 (de) | 2004-01-10 | 2005-01-07 | Arzneimittel zur topischen applikation bei tieren |
Country Status (11)
Country | Link |
---|---|
US (1) | US20080255125A1 (de) |
EP (1) | EP1706097A2 (de) |
JP (1) | JP5704738B2 (de) |
AU (1) | AU2005203884B2 (de) |
BR (1) | BRPI0506753A (de) |
CA (1) | CA2552909C (de) |
DE (1) | DE102004001558A1 (de) |
NO (1) | NO20063626L (de) |
NZ (1) | NZ548422A (de) |
WO (1) | WO2005065713A2 (de) |
ZA (1) | ZA200605611B (de) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102005011779A1 (de) * | 2005-03-11 | 2006-09-14 | Bayer Healthcare Ag | Endoparasitizide Mittel |
DE102006010643A1 (de) * | 2006-03-08 | 2007-09-13 | Bayer Healthcare Aktiengesellschaft | Arzneimittel enthaltend Fluorchinolone |
DE102006038292A1 (de) * | 2006-08-16 | 2008-02-21 | Bayer Healthcare Ag | Transdermale Anwendung von Triazinen zur Bekämpfung von Coccidien-Infektionen |
DE102007055341A1 (de) * | 2007-11-19 | 2009-05-20 | Bayer Animal Health Gmbh | Stabilisierung öliger Suspensionen enthaltend hydrophobe Kieselsäuren |
DE102009012423A1 (de) * | 2009-03-10 | 2010-09-16 | Bayer Animal Health Gmbh | Zubereitung auf Ölbasis |
CN103315986B (zh) * | 2013-05-24 | 2014-09-03 | 湖北龙翔药业有限公司 | 一种可溶且稳定的帕托珠利组合物及其制备方法 |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4402941A (en) * | 1981-09-15 | 1983-09-06 | Marc Vaillancourt | Veterinary composition for preventing feline urological syndrome and litter product containing the composition |
EP0659410A2 (de) * | 1990-07-14 | 1995-06-28 | ASTA Medica Aktiengesellschaft | Verwendung des Wirkstoffs Flupirtin zur Bekämpfung von Muskelverspannungen |
WO1997042954A1 (en) * | 1996-05-10 | 1997-11-20 | Pharmacia & Upjohn Company | Topical administration of antimicrobial agents for the treatment of systemic bacterial diseases |
WO1999062519A1 (de) * | 1998-06-02 | 1999-12-09 | Bayer Aktiengesellschaft | Halbfeste wässrige zubereitungen für orale applikation von toltrazuril-sulfon |
WO2000074714A2 (en) * | 1999-06-03 | 2000-12-14 | Glenn Gregory M | Indicators for monitoring the technique of transcutaneous immunization |
WO2001008682A2 (de) * | 1999-08-03 | 2001-02-08 | Awd.Pharma Gmbh & Co. Kg | Verwendung von flupirtin zur linderung von schmerzen bei degenerativen gelenkerkrankungen von hunden und katzen |
US6191143B1 (en) * | 1996-05-10 | 2001-02-20 | Pharmacia & Upjohn Company | Topical administration of antimicrobial agents for the treatment of systemic bacterial diseases |
WO2002014288A1 (de) * | 2000-08-17 | 2002-02-21 | Bayer Aktiengesellschaft | Verwendung von triazintrion-sulfonen zur bekämpfung von coccidiosen |
WO2003101422A2 (de) * | 2002-05-31 | 2003-12-11 | Bayer Healthcare Ag | Pharmazeutiche zubereitungen zur oralen anwendung enthaltend wirkstoffbeladene ionentauscherharze sowie strukturviskose gelbildner als verdicker |
WO2004047795A2 (de) * | 2002-11-28 | 2004-06-10 | Bayer Healthcare Ag | Dermale applikation von flupirtin |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5122377A (en) * | 1990-11-19 | 1992-06-16 | A.H. Robins, Company, Incorporated | Oral delivery system for veterinary drugs |
EP0684759A4 (de) * | 1992-09-30 | 1996-05-08 | Cornell Res Foundation Inc | Transgenischem apfelartigem obst mit feuerbrandresistenz. |
EP1119255A4 (de) * | 1998-10-08 | 2009-04-15 | New Ace Res Company | Neue zusammensetzungen und verfahren zur vorbeugung und behandlung von protozoenerkrankungen |
US6150361A (en) * | 1998-12-22 | 2000-11-21 | Bayer Corporation | Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma |
ATE376422T1 (de) * | 2003-01-16 | 2007-11-15 | Janssen Pharmaceutica Nv | Diclazurilhaltige antiprotozoenmittel |
-
2004
- 2004-01-10 DE DE102004001558A patent/DE102004001558A1/de not_active Withdrawn
-
2005
- 2005-01-07 WO PCT/EP2005/000067 patent/WO2005065713A2/de active Application Filing
- 2005-01-07 US US10/585,608 patent/US20080255125A1/en not_active Abandoned
- 2005-01-07 CA CA2552909A patent/CA2552909C/en not_active Expired - Fee Related
- 2005-01-07 EP EP05700727A patent/EP1706097A2/de not_active Withdrawn
- 2005-01-07 BR BRPI0506753-7A patent/BRPI0506753A/pt not_active Application Discontinuation
- 2005-01-07 JP JP2006548218A patent/JP5704738B2/ja not_active Expired - Fee Related
- 2005-01-07 AU AU2005203884A patent/AU2005203884B2/en not_active Ceased
- 2005-01-07 NZ NZ548422A patent/NZ548422A/en not_active IP Right Cessation
-
2006
- 2006-07-07 ZA ZA200605611A patent/ZA200605611B/en unknown
- 2006-08-10 NO NO20063626A patent/NO20063626L/no not_active Application Discontinuation
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4402941A (en) * | 1981-09-15 | 1983-09-06 | Marc Vaillancourt | Veterinary composition for preventing feline urological syndrome and litter product containing the composition |
EP0659410A2 (de) * | 1990-07-14 | 1995-06-28 | ASTA Medica Aktiengesellschaft | Verwendung des Wirkstoffs Flupirtin zur Bekämpfung von Muskelverspannungen |
WO1997042954A1 (en) * | 1996-05-10 | 1997-11-20 | Pharmacia & Upjohn Company | Topical administration of antimicrobial agents for the treatment of systemic bacterial diseases |
US6191143B1 (en) * | 1996-05-10 | 2001-02-20 | Pharmacia & Upjohn Company | Topical administration of antimicrobial agents for the treatment of systemic bacterial diseases |
WO1999062519A1 (de) * | 1998-06-02 | 1999-12-09 | Bayer Aktiengesellschaft | Halbfeste wässrige zubereitungen für orale applikation von toltrazuril-sulfon |
WO2000074714A2 (en) * | 1999-06-03 | 2000-12-14 | Glenn Gregory M | Indicators for monitoring the technique of transcutaneous immunization |
WO2001008682A2 (de) * | 1999-08-03 | 2001-02-08 | Awd.Pharma Gmbh & Co. Kg | Verwendung von flupirtin zur linderung von schmerzen bei degenerativen gelenkerkrankungen von hunden und katzen |
WO2002014288A1 (de) * | 2000-08-17 | 2002-02-21 | Bayer Aktiengesellschaft | Verwendung von triazintrion-sulfonen zur bekämpfung von coccidiosen |
WO2003101422A2 (de) * | 2002-05-31 | 2003-12-11 | Bayer Healthcare Ag | Pharmazeutiche zubereitungen zur oralen anwendung enthaltend wirkstoffbeladene ionentauscherharze sowie strukturviskose gelbildner als verdicker |
WO2004047795A2 (de) * | 2002-11-28 | 2004-06-10 | Bayer Healthcare Ag | Dermale applikation von flupirtin |
Non-Patent Citations (1)
Title |
---|
CÉLINE LAFFONT ET AL: "Licking behaviour and envoronmental contamination arising from pour-on ivermectin for cattle", INT. J. OF PARASITOLOGY, vol. 31, 2001, pages 1687 - 1692, XP008057275 * |
Also Published As
Publication number | Publication date |
---|---|
US20080255125A1 (en) | 2008-10-16 |
NO20063626L (no) | 2006-10-10 |
CA2552909A1 (en) | 2005-07-21 |
ZA200605611B (en) | 2007-11-28 |
JP5704738B2 (ja) | 2015-04-22 |
CA2552909C (en) | 2014-05-27 |
NZ548422A (en) | 2010-04-30 |
WO2005065713A2 (de) | 2005-07-21 |
JP2007519637A (ja) | 2007-07-19 |
AU2005203884A1 (en) | 2005-07-21 |
AU2005203884B2 (en) | 2011-04-14 |
EP1706097A2 (de) | 2006-10-04 |
DE102004001558A1 (de) | 2005-08-18 |
BRPI0506753A (pt) | 2007-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LTC1620113I2 (lt) | Ivermektino topinė kompozicija, skirta dermatologinių susirgimų gydymui | |
WO2007038459A3 (en) | Carboxyamine compounds and their use in the treatment of hdac dependent diseases | |
WO2006003492A3 (en) | Compositions and methods for treating pathological infections | |
WO2006131721A3 (en) | Topical ungual formulations | |
WO2006127899A3 (en) | (r)-n-methylnaltrexone, processes for its synthesis and its pharmaceutical use | |
WO2010010470A3 (en) | Methods of administering topical antifungal formulations for the treatment of fungal infections | |
EP2450360A3 (de) | (S)-N-Methylnaltrexon | |
WO2007046097A3 (en) | Topical compositions for the treatment of depilation-induced skin irritation or prevention thereof | |
WO2004103960A3 (en) | Compounds and uses thereof | |
WO2005086656A3 (en) | Heteroarylaminopyrazole derivatives useful for the treatment of diabetes | |
WO2006060515A3 (en) | System for improved percutaneous absorption of skin benefiting agents | |
WO2006075095A3 (fr) | Utilisation de derives de la purine comme inhibiteurs de la proteine hsp90 et pour le traitement du cancer | |
WO2008076954A3 (en) | Heterocycle compounds and methods of use thereof | |
WO2007025632A3 (en) | Nitrooxy derivatives op glucocorticoids | |
WO2008087367A3 (fr) | Derives de (phenylthiazolyl)-phenyl-propan-1-one et de (phenyloxazodyl)-phenyl-propan-1-one substitues, preparations et utilisations | |
WO2006123031A3 (fr) | Composition pharmaceutique comprenant un onguent oleagineux et de la vitamine d ou l’un de ses derives a l'etat solubilise | |
WO2009041663A1 (ja) | 皮膚疾患の予防及び/または治療剤 | |
WO2009071689A3 (de) | 5-halogen-substituierte oxindol-derivate und ihre verwendung zur behandlung von vasopressin-abhängigen erkrankungen | |
NO20071798L (no) | Dermalt pafore formuleringer for behandling av hudsykdommer i dyr | |
WO2005065713A3 (de) | Arzneimittel zur topischen applikation bei tieren | |
WO2005089294A3 (en) | Synthesis of indenoisoquinoliniums and methods of use | |
ATE424823T1 (de) | 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin- derivate als arzneimittel zur behandlung von unfruchtbarkeit | |
WO2007144521A3 (fr) | Composition cosmetique a usage topique comprenant du wasabi | |
WO2006102604A8 (en) | Topical formulations of borinic acid antibodies and their methods of use | |
WO2007009686A3 (en) | Substituted pyrazoline compounds, their preparation and use as medicaments |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
REEP | Request for entry into the european phase |
Ref document number: 2005700727 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005700727 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2006/007717 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006/05611 Country of ref document: ZA Ref document number: 548422 Country of ref document: NZ Ref document number: 200605611 Country of ref document: ZA Ref document number: 2552909 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006548218 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005203884 Country of ref document: AU |
|
ENP | Entry into the national phase |
Ref document number: 2005203884 Country of ref document: AU Date of ref document: 20050107 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2005203884 Country of ref document: AU |
|
WWP | Wipo information: published in national office |
Ref document number: 2005700727 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: PI0506753 Country of ref document: BR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10585608 Country of ref document: US |